124 related articles for article (PubMed ID: 25768106)
1. Clinical scenario 2: Exploring treatment options for patients with symptomatic, progressive GEP-NETs.
Pape UF
Clin Adv Hematol Oncol; 2014 Dec; 12(12 Suppl 19):20-2. PubMed ID: 25768106
[No Abstract] [Full Text] [Related]
2. Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide.
Ricci S; Antonuzzo A; Galli L; Ferdeghini M; Bodei L; Orlandini C; Conte PF
Ann Oncol; 2000 Sep; 11(9):1127-30. PubMed ID: 11061606
[TBL] [Abstract][Full Text] [Related]
3. AACE/ACE disease state clinical review: diagnosis and management of midgut carcinoids.
Liu EH; Solorzano CC; Katznelson L; Vinik AI; Wong R; Randolph G
Endocr Pract; 2015 May; 21(5):534-545. PubMed ID: 25962092
[TBL] [Abstract][Full Text] [Related]
4. [Current treatment of carcinoid tumor].
Elizalde I; Borda F
Gastroenterol Hepatol; 2002 Oct; 25(8):508-13. PubMed ID: 12361534
[No Abstract] [Full Text] [Related]
5. Metastatic midgut carcinoid to the heart demonstrated on cardiac magnetic resonance imaging.
Pasieka JL; Schnell G; Abdel-Aty H; Rorstad O
Am J Clin Oncol; 2009 Jun; 32(3):328-9. PubMed ID: 19887994
[No Abstract] [Full Text] [Related]
6. The tumour vanishes.
Todd JF; Meeran K
Clin Endocrinol (Oxf); 2000 Dec; 53(6):663-4. PubMed ID: 11155085
[No Abstract] [Full Text] [Related]
7. Carcinoid of the pancreas.
Migliori M; Tomassetti P; Lalli S; Casadei R; Santini D; Corinaldesi R; Gullo L
Pancreatology; 2002; 2(2):163-6. PubMed ID: 12123097
[TBL] [Abstract][Full Text] [Related]
8. A stepwise approach to the management of metastatic midgut carcinoid tumor.
Bhattacharyya S; Gujral DM; Toumpanakis C; Dreyfus G; Davidson BR; Davar J; Caplin ME
Nat Rev Clin Oncol; 2009 Jul; 6(7):429-33. PubMed ID: 19561636
[TBL] [Abstract][Full Text] [Related]
9. Carcinoid tumors--somatostatine in the diagnosis and therapy.
Kinova S; Duris I; Kratochvilova E; Ondrejka P; Payer J
Bratisl Lek Listy; 2002; 103(3):108-12. PubMed ID: 12190042
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine tumours of the small intestine.
Strosberg J
Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):755-73. PubMed ID: 23582917
[TBL] [Abstract][Full Text] [Related]
11. Neurokinin A monitoring of response to interferon alpha in a patient with an advanced small bowel neuroendocrine tumour uncontrolled by somatostatin analogue therapy.
Ardill JE; Johnston BT; McCance DR; Eatock M
Ann Clin Biochem; 2017 Mar; 54(2):297-301. PubMed ID: 27638929
[TBL] [Abstract][Full Text] [Related]
12. [All patients in Sweden with metastazing carcinoid tumors in the small intestine will be studied].
Ahrén B; Ahlman H; Cedermark B; Grimelius L; Akerström G; Oberg K
Lakartidningen; 1991 Apr; 88(16):1489-90. PubMed ID: 2023499
[No Abstract] [Full Text] [Related]
13. Carcinoid encephalopathy: A single entity or a spectrum of different disorders?
Lapeire LD; Tansens A; Lemmens GM; Van Belle SJ
Acta Oncol; 2010; 49(2):268-70. PubMed ID: 20001498
[No Abstract] [Full Text] [Related]
14. Carcinoid tumour management in haemodialysis: a case report.
Burke MT; Gray NA
Nephrology (Carlton); 2012 Feb; 17(2):198. PubMed ID: 22257155
[No Abstract] [Full Text] [Related]
15. Liver metastases of digestive endocrine tumours: natural history and response to medical treatment.
Skinazi F; Zins M; Menu Y; Bernades P; Ruszniewski P
Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):673-8. PubMed ID: 8853257
[TBL] [Abstract][Full Text] [Related]
16. Metastatic carcinoid tumour of the heart.
Debouverie O; Vaquette B; Hervochon JM
Arch Cardiovasc Dis; 2010; 103(8-9):491-2. PubMed ID: 21074130
[No Abstract] [Full Text] [Related]
17. [Carcinoid tumors].
Pregun I; Bodoky G; Rácz K; Tulassay Z
Orv Hetil; 2010 Nov; 151(46):1885-94. PubMed ID: 21044939
[TBL] [Abstract][Full Text] [Related]
18. Interferon-alpha induces bcl-2 proto-oncogene in patients with neuroendocrine gut tumor responding to its antitumor action.
Imam H; Gobl A; Eriksson B; Oberg K
Anticancer Res; 1997; 17(6D):4659-65. PubMed ID: 9494585
[TBL] [Abstract][Full Text] [Related]
19. Comment of long-acting lanreotide inducing clinical and biochemical remission of acromegaly caused by disseminated GHRH secreting carcinoid.
Krassowski J; Zgliczyński W; Jeske W; Zgliczyński S
J Clin Endocrinol Metab; 1999 May; 84(5):1761-2. PubMed ID: 10323416
[No Abstract] [Full Text] [Related]
20. Biology and management of the midgut carcinoid.
Basson MD; Ahlman H; Wangberg B; Modlin IM
Am J Surg; 1993 Feb; 165(2):288-97. PubMed ID: 8427415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
